期刊文献+

采用单点双注法制备帕金森病大鼠模型 被引量:5

A new parkinsonian rat model established via striatum one-spot/twice-injection
原文传递
导出
摘要 目的探讨单点双注法制备帕金森病(Parkison's disease,PD)大鼠模型的可行性。方法分别以两点法和单点双注法注射6-羟基多巴胺(6-OHDA)于纹状体,研究二者模型成功率、平均转速与酪氨酸羟化酶(tyrosine hydroxylase,TH)阳性细胞数。结果单点双注法与两点法大鼠模型成功率、平均转速与TH阳性细胞数无显著性差异。结论6-OHDA纹状体单点双注法制备PD大鼠模型是可行的。 Objective To explore the feasibility of establishing Parkinsonian rat model via one-- spot/twice-- injection. Methods 6-hydroxydopamine (6-OHDA) were administered into striatum from one spot or two spots, the model success ratios, the average rotation speeds and the numbers of tyrosine hydroxylase(TH)--positive neurons were studied. Results The model suc- cess ratios, the average rotation speeds and the numbers of TH-positive neurons of two groups receiving 6-OHDA via one--spot/twice--injection and two-spot injection were not significantly different. Conclusion Parkinsonian rat model can be established via striatum one-spot/twice-injection.
出处 《立体定向和功能性神经外科杂志》 2008年第5期263-265,共3页 Chinese Journal of Stereotactic and Functional Neurosurgery
关键词 帕金森病 6-OHDA 纹状体 大鼠 Parkison's disease 6-OHDA Striatum Rat
  • 相关文献

参考文献11

  • 1张伟,杨辉.6-OHDA制作帕金森病大鼠模型及评估[J].四川医学,2007,28(8):818-820. 被引量:11
  • 2Paxinos G, Watson C. The rat brain in stereotaxic coordinates[M], 5th Edition, 2005, Electronic press. 128-140.
  • 3Haobam R, Sindhu KM, Chandra G, el al. Swim-test as a function of moto impairment in MPTP model of Parkinson's disease: A comparative study in two mouse strains[J]. Behavioural Brain Research, 2005, 163(2) : 159-167.
  • 4尹丰,田增民,赵全军,王亚明,于雪,刘爽.6-羟基多巴脑内注射建立帕金森病大鼠模型的实验研究[J].海军总医院学报,2007,20(2):75-79. 被引量:4
  • 5Ungerstedt U, Arburthnott GW. Quantitative recording of rotational behaviour in rats after 6-hydroxydopamine lesions of the nigrostriatal dopamine system[J]. Brain Res, 1970, 24: 485-493.
  • 6Kumar R, Agarwal Ak, Seth PK. Free radical-generated neurotoxicity of 6- hydroxydopamine[J]. J Neuro Chem, 1995, 64(4): 1703-1707.
  • 7Glinka YY, Youdim MB. Inhibition of mitochondrial complexes Ⅰ and Ⅳ by 6-hydroxydopamine[J]. Eur J Pbarmacol, 1995, 292(Suppl3-4): 329-332.
  • 8Lee JH, Zhu WM, Stanic D, et al. Sprouting of dopamine terminals and altered dopamine release and uptake in Parkinsonian dyskinaesia[J]. Brain, 2008, 131(6): 1574-1587.
  • 9Breysse N, Baunez C, Spooren W, et al. Chronic But Not Acute Treatment with a Metabotropic Glutamate 5 Receptor Antagonist Reverses the Akinetic Deficits in a Rat Model of Parkinsonism[J]. Neuroscience, 2002, 22 (13) : 5669-5678.
  • 10Ahmad M, Saleem S, Ahmad AS, et al. Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsonism in rats[J]. Human & Experimental Toxicology, 2005, 24: 137-147.

二级参考文献21

  • 1周明付,张华,吴金良,郭漳生,林玲,汤善钧,周祥庭.大鼠帕金森氏病模型的建立[J].河南医科大学学报,1994,29(4):289-292. 被引量:14
  • 2徐仁伵.帕金森病发病与部分金属元素含量变化可能有关[J].国外医学(老年医学分册),2005,26(6):251-255. 被引量:5
  • 3包新民,舒斯云.大鼠脑立体定向图谱[M].北京:人民卫生出版社,1988:16-31.
  • 4Nikkhah G,Ollson M,Eberhard J,et al.A microtransplantation approach for cell suspension grafting in the rat Parkinson model:a detailed account of the methodology[J].Neuroscience,1994,63(1):57-62.
  • 5Dunnett SB,Bjorklund A,Stenevi U,et al.Behavioral reco-ver following transplantation of substantia nigro subjected to 6-OHDA lesions of the nigrostriatal pathway.Ⅰ.Unila-teral lesions[J].Brain Res,1981,215(1-2):147-161.
  • 6Ungerstedt U.6-Hydroxydopamine induced degeneration of central monoamine neurons[J].Eur J Pharmacol,1968,15(1):107-110.
  • 7Sotelo C,Javoy F,Agid Y,et al.Injection of 6-hydroxydopamine in the substantia nigra of the rat.Ⅰ.Morphological study[J].Brain Res,1973,58(2):269-290.
  • 8Brecknell JE,Dunnett SB,Fawcett JW.A quantitative study of cell death in the substantia nigra following a mechanical lesion of the medial forebrain bundle[J].Neuroscience,1995,64(1):219-227.
  • 9Zetterstroem T,Brundin P,Gage FH,et al.In vivo measurement of spontaneous release and metabolism of dopamine from intrastriatal nigral grafts using intracerebral dialysis[J].Brain Res,1986,362(2):344-349.
  • 10Lee CS,Sauer H,Bjorklund A,et al.Dopaminergic neuronal degeneration and motor impairments following axon terminal lesion by intrastriata 6-hydroxydopamine in the rat[J].Neuroscience,1996,72(3):641-653.

共引文献12

同被引文献31

  • 1吴均,杨慧.帕金森病动物模型研究进展[J].中国比较医学杂志,2005,15(2):124-128. 被引量:3
  • 2牛朝诗,傅先明.帕金森病常用动物模型制作及其进展[J].中华神经医学杂志,2005,4(5):521-524. 被引量:11
  • 3冯敏,王莎莉.帕金森病发病机理的研究进展[J].国外医学(老年医学分册),2005,26(6):247-251. 被引量:8
  • 4Blum D,Torch S,Lambeng N,et al.Molecular pathway involved in the neurotoxicity of 6-OHDA,dopamine and MPTP:contribution to the apoptotic theory in Parkinson's disease[J].Prog Neurobiol,2001,65(2):135-172.
  • 5Iancu R,Mohapel P,Brundin P,et al.Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice[J].Behav Brain Res,2005,162(1):1-10.
  • 6Carvey PM,Punati A,Newman MB.Progressive dopamine neuron loss in Parkinson's disease:the multiple hit hypothesis[J].Cell Transplant,2006,15(3):239-250.
  • 7王月平,王举磊,高国栋.帕金森病大鼠丘脑底核的时间相关性放电模式分析[J].神经解剖学杂志,2007,23(5):485-488. 被引量:4
  • 8Paxinos G, Watson C. The rat brain stereotaxic coordinates [ M ]. Academic Press Sydney, 1985, 25 : 87 -92.
  • 9Schober A. Classic toxin-induced animal models of Parkinson's dis- ease : 6-OHDA and MPTP[ J ]. Cell Tissue Res, 2004, 318:215 - 224.
  • 10Litvan I, Halliday G, Hallett M, et al. The etiopathogenesis of Par- kinson disease and suggestions for future research[ J]. Neuropathol Exp Neurol, 2007, 66:251 -257.

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部